Mason Carrico

Stock Analyst at Stephens & Co.

(0)
# 4665
Out of 5,338 analysts
83
Total ratings
21.54%
Success rate
-18.14%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
PACB Pacific Biosciences
Reiterates: Overweight
2 2
1.06 69.81% 5 May 15, 2025
TXG 10x Genomics
Reiterates: Overweight
14 14
9.18 52.51% 6 May 15, 2025
HOLX Hologic
Maintains: Overweight
77 70
55.74 25.58% 4 May 13, 2025
CDNA CareDx
Reiterates: Overweight
40 40
16.11 148.29% 10 May 5, 2025
GKOS Glaukos
Maintains: Overweight
140 115
91.64 25.49% 1 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
45 45
28.43 58.28% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
4 4
2.69 48.7% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
55 55
40.4 36.14% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 2
1 80% 6 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
6 6
2.69 123.05% 2 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
17 17
18.27 -6.95% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
156 156
80.84 92.97% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
52 52
36.59 42.12% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 13
n/a n/a 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
20 20
4.1 387.8% 4 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
41.47 56.74% 1 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
41 41
16.44 149.39% 7 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
125 125
149.15 -16.19% 4 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
19 19
7.83 142.66% 1 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
2 2
n/a n/a 4 Apr 19, 2024